Rainbow Seed Fund News

MARLOW & NOTTINGHAM, UK. — April 8, 2019 – UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board. Dr Nel Moore has considerable experience in drug development with a track record taking therapeutics to market as former Global Product Vice President at […]

read more

Cambridge, UK, 21 March 2019 – Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T-cell enhancing therapeutics, announces winning the award for “Life Science Innovation” at the Business Weekly Awards 2019. The “Life Science Innovation” award recognises “the organisation or individual who has done the most to further the cause of life science […]

read more

Today marks the launch of Bio-start, an annual competition designed to bolster UK companies aiming to solve significant global problems through synthetic biology. Competition founders SynbiCITE and UK Innovation & Science Seed Fund have created Bio-start to incentivise innovative early-stage companies and people with great engineering biology ideas. The not-for-profit competition offers the winner a […]

read more